We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLAHW
12001
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Warrant
HLAHW
$183K ﹤0.01%
228,623
+4,991
+2% +$4.08K
TUFN
12002
PUT
DELISTED
Tufin Software Technologies Ltd.
TUFN
$183K ﹤0.01%
18,600
-9,100
-33% -$94.5K
EMWP
12003
DELISTED
Eros Media World PLC
EMWP
$183K ﹤0.01%
9,949
-4,507
-31% -$86.1K
VGII.WS
12004
DELISTED
Virgin Group Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one Class
VGII.WS
$183K ﹤0.01%
212,748
-607
-0.3% -$653
AQST icon
12005
Aquestive Therapeutics
AQST
$471M
$182K ﹤0.01%
+41,711
New +$164K
CLBT icon
12006
PUT
Cellebrite
CLBT
$3.9B
$182K ﹤0.01%
+19,600
New +$205K
IEZ icon
12007
PUT
iShares US Oil Equipment & Services ETF
IEZ
$359M
$182K ﹤0.01%
13,300
-200
-1% -$2.67K
NFBK
12008
CALL
DELISTED
Northfield Bancorp
NFBK
$182K ﹤0.01%
10,600
-2,600
-20% -$42.8K
TXMD icon
12009
CALL
TherapeuticsMD
TXMD
$24M
$182K ﹤0.01%
4,922
+280
+6% +$12.4K
THCX
12010
CALL
DELISTED
AXS Cannabis ETF
THCX
$182K ﹤0.01%
1,420
-770
-35% -$113K
COVAU
12011
DELISTED
COVA Acquisition Corp. Unit
COVAU
$182K ﹤0.01%
18,286
-233,190
-93% -$2.33M
BFIN
12012
DELISTED
BankFinancial
BFIN
$181K ﹤0.01%
+15,806
New +$180K
FBIO icon
12013
Fortress Biotech
FBIO
$92.7M
$181K ﹤0.01%
3,747
+685
+22% +$33.4K
LCTX icon
12014
Lineage Cell Therapeutics
LCTX
$284M
$181K ﹤0.01%
71,856
-2,448
-3% -$6.28K
GMDA
12015
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$181K ﹤0.01%
46,075
+6,449
+16% +$32.2K
ONCT
12016
PUT
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$181K ﹤0.01%
2,170
-1,665
-43% -$138K
BGRY
12017
PUT
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$181K ﹤0.01%
+25,700
New +$220K
NAACW
12018
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
$181K ﹤0.01%
242,266
-1,784
-0.7% -$1.68K
CRHC.U
12019
DELISTED
Cohn Robbins Holdings Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CRHC.U
$181K ﹤0.01%
17,825
-2,883
-14% -$29.3K
ACII.WS
12020
DELISTED
Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
ACII.WS
$181K ﹤0.01%
212,042
+73,825
+53% +$78.3K
ODT
12021
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$181K ﹤0.01%
62,365
-110,624
-64% -$368K
GIGGU
12022
DELISTED
GigCapital4, Inc. Unit
GIGGU
$181K ﹤0.01%
17,765
-11,030
-38% -$112K
GLAD icon
12023
PUT
Gladstone Capital
GLAD
$431M
$180K ﹤0.01%
7,950
-1,050
-12% -$24.2K
WWR icon
12024
CALL
Westwater Resources
WWR
$54.1M
$180K ﹤0.01%
50,300
-79,300
-61% -$310K
XFOR icon
12025
X4 Pharmaceuticals
XFOR
$391M
$180K ﹤0.01%
1,131
-438
-28% -$72.1K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.